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Abstract
Background
Total thyroidectomy (TT) and subtotal thyroidectomy (ST) are worldwide treatment options for multinodular non-toxic goitre in
adults. Near TT, defined as a postoperative thyroid remnant less than 1 mL, is supposed to be a similarly effective but safer
option than TT. ST has been shown to be marginally safer than TT, but it may leave an undetected thyroid cancer in place.
Objectives
The objective was to assess the effects of total or near-total thyroidectomy compared to subtotal thyroidectomy for
multinodular non-toxic goitre.
Search methods
We searched the Cochrane Library, MEDLINE, PubMed, EMBASE, as well as the ICTRP Search Portal and
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ClinicalTrials.gov. The date of the last search was 18 June 2015 for all databases. No language restrictions were applied.
Selection criteria
Two review authors independently scanned the abstract, title or both sections of every record retrieved to identify
randomised controlled trials (RCTs) on thyroidectomy for multinodular non-toxic goitre for further assessment.
Data collection and analysis
Two review authors independently extracted data, assessed studies for risk of bias and evaluated overall study quality
utilising the GRADE instrument. We calculated the odds ratio (OR) and corresponding 95% confidence interval (CI) for
dichotomous outcomes. A random-effects model was used for pooling data.
Main results
We examined 1430 records, scrutinized 14 full-text publications and included four RCTs. Altogether 1305 participants
entered the four trials, 543 participants were randomised to TT and 762 participants to ST. A total of 98% and 97% of
participants finished the trials in the TT and ST groups, respectively. Two trials had a duration of follow-up between 12 and
39 months and two trials a follow-up of 5 and 10 years, respectively. Risk of bias across studies was mainly unknown for
selection, performance and detection bias. Attrition bias was generally low and reporting bias high for some outcomes. In the
short-term postoperative period no deaths were reported for both TT and ST groups. However, longer-term data on all-cause
mortality were not reported (1284 participants; 4 trials; moderate quality evidence). Goiter recurrence was lower in the TT
group compared to ST. Goiters recurred in 0.2% (1/425) of the TT group compared to 8.4% (53/632) of the ST group (OR
0.05 (95% CI 0.01 to 0.21); P < 0.0001; 1057 participants; 3 trials; moderate quality evidence). Re-intervention due to goitre
recurrence was lower in the TT group compared to ST. Re-intervention was necessary in 0.5% (1/191) of TT patients
compared to 0.8% (3/379)of ST patients (OR 0.66 (95% CI 0.07 to 6.38); P = 0.72; 570 participants; 1 trial; low quality
evidence). The incidence of permanent recurrent laryngeal nerve palsy was lower for ST compared with TT. Permanent
recurrent laryngeal nerve palsy occurred in 0.8% (6/741) of ST patients compared to 0.7% (4/543) of TT patients (OR 1.28,
(95% CI 0.38 to 4.36); P = 0.69; 1275 participants; 4 trials; low quality evidence). The incidence of permanent
hypoparathyroidism was lower for ST compared with TT. Permanent hypoparathyroidism occurred in 0.1% (1/741) of ST
patients compared to 0.6% (3/543) of TT patients (OR 3.09 (95% CI 0.45 to 21.36); P = 0.25; 1275 participants: 4 trials; low
quality evidence). The incidence of thyroid cancer was lower for ST compared with TT. Thyroid cancer occurred in 6.1%
(41/669) of ST patients compared to 7.3% (34/465)of TT patients (OR 1.32 (95% CI 0.81 to 2.15); P = 0.27; 1134
participants; 3 trials; low quality evidence). No data on health-related quality of life or socioeconomic effects were reported in
the included studies.
Authors' conclusions
The body of evidence on TT compared with ST is limited. Goiter recurrence is reduced following TT. The effects on other key
outcomes such as re-interventions due to goitre recurrence, adverse events and thyroid cancer incidence are uncertain. New
long-term RCTs with additional data such as surgeons level of experience, treatment volume of surgical centres and details
on techniques used are needed.
Plain language summary
Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
Review question
What are the effects of total or near-total thyroidectomy compared with subtotal thyroidectomy for multinodular non-toxic
goitre in adults?
Background
Multinodular goitre refers to a generalised enlarged thyroid gland with recognisable nodules within it. The thyroid gland
consists of two connected lobes. People affected by goitre often present with a non-symmetrical enlargement of the thyroid
gland with a visible swelling in the anterior aspect of the neck. One or more nodules can be recognised. The most frequent
cause of multinodular goitre is iodine deficiency. Non-toxic goitre means that the nodules do not secret thyroid hormones in
an uncontrolled way. Total thyroidectomy is an operation that involves the surgical removal of the whole thyroid gland. Near-
total thyroidectomy is an operation that involves the surgical removal of both thyroid lobes except for a small amount of
thyroid tissue (on one or both sides less than 1.0 mL). Subtotal thyroidectomy leaves 3 g to 5 g on the less affected side of
the thyroid gland.
After thyroidectomy one of the most important complications is recurrent nerve palsy because this nerve might be
traumatised during the surgery. A wide spectrum of complications to the voice, swallowing mechanisms, or both, can occur.
A temporary or permanent voice change can result. If the goitre reappears (goitre recurrence) some time after thyroidectomy,
another surgical intervention might be necessary. This surgery is more complicated than the initial surgery because of scar
tissue making it difficult to identify nerves and other important tissues. There is also the possibility that subtotal
thyroidectomy, which is thought to be somewhat safer than total thyroidectomy, may leave an undetected thyroid cancer in
place.
Study characteristics
We included four randomised controlled trials with a total of 1305 participants. A total of 543 participants were randomised to
total or near-total thyroidectomy and 762 participants to subtotal thyroidectomy. Two trials had a duration of follow-up
between 12 and 39 months and two trials a follow-up of 5 and 10 years, respectively. Most participants were women and the
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average age was around 50 years.
Key results
In the short-term period after surgery no deaths were reported for both total thyroidectomy and subtotal thyroidectomy
groups, however longer-term data on all-cause mortality were not reported. Goitre recurrence was lower for total
thyroidectomy compared to subtotal thyroidectomy: the risk for goitre recurrence was 84 per 1000 trial participants for
subtotal thyroidectomy and 5 per 1000 participants (with a possible range of 1 to 19) for total thyroidectomy. There was no
clear benefit or harm of either surgical technique for re-operations because of goitre recurrence, side effects like permanent
recurrent laryngeal nerve palsy or development of thyroid cancer. No data on health-related quality of life or socioeconomic
effects were reported in the included trials.
Quality of the evidence
The overall quality was low to moderate, mainly because of the small number of studies and participants as well as low rates
of events which makes distinction between harms and benefits of the two surgical techniques difficult.
Currentness of evidence
This evidence is up to date as of June 2015.
Background 
Multinodular non-toxic goitre is the most common endocrine condition, consisting of a nodular overgrowth of the thyroid gland
which is not associated with either malignancy or hyperthyroidism. This can be treated conservatively, but in the vast majority
of cases it needs surgical intervention. The indications for surgical treatment of multinodular non-toxic goitre are:
large size goitre or increase in size despite treatment with thyroid-stimulating hormone (TSH);
compression symptoms (i.e. dyspnoea or dysphagia);
suspected or proven malignant changes; and
cosmetic reasons.
The optimal surgical procedure for multinodular non-toxic goitre is still debated. Surgeons may decide to remove the entire
thyroid gland in a single operation (total thyroidectomy) or to limit the resection to only part of the thyroid tissue (subtotal
thyroidectomy), in order to remove only the diseased part and thus minimise the risk of recurrent nerve palsy and
hypocalcaemia, which are more frequently associated with total thyroidectomy. Total thyroidectomy has the advantage of
one-stage removal of incidental thyroid cancer and a lower risk of developing recurrent goitre. In addition, in total
thyroidectomy there is no consensus on the safety and cost-effectiveness of the use of the clamp and tie technique versus
the use of a diathermy (i.e. electrically induced heat) system for vessel ligation and division (i.e. LigaSure or Ultracision) (
Cirocchi 2010).
Developments in surgical technique including systematic identification of recurrent laryngeal nerve palsy, and intraoperative
neuro-monitoring have led to a reduction in the incidence of recurrent nerve lesions and post-surgical hypoparathyroidism (
Donatini 2012).
Although this topic has been the subject of several studies (Foster 1978; Perzik 1976), the question of which of the two
surgical procedures (i.e. total or subtotal thyroidectomy) should be performed remains unanswered.
Description of the condition
The term multinodular goitre describes an enlarged, diffusely heterogeneous thyroid gland. Initial findings may include diffuse
enlargement, but asymmetrical nodularity of the mass often develops. Multinodular goitre refers to a generalised enlarged
thyroid gland with recognisable nodules within it. Patients affected by this condition often present with a non-symmetrical
enlargement of the thyroid gland with a visible swelling in the anterior aspect of the neck and a heterogeneously rough
surface on palpation. One or more nodules can be recognised. The most frequent cause of multinodular goitre is iodine
deficiency.
Description of the intervention
Total thyroidectomy is an operation that involves the surgical removal of the whole thyroid gland, with the preservation of the
parathyroid glands. A small transverse incision is performed in the inferior portion of the neck at the level of one of the natural
creases, 2 to 3 cm above the sternal notch. The platysma is divided and the skin flaps are elevated superiorly and inferiorly.
The midline is divided on avascular plane and the strap muscles are retracted laterally and the thyroid is retracted medially.
Using blunt dissection the thyroid is dissected from the surrounding structures and then a ligation of the inferior and superior
pole vessels is performed. The inferior laryngeal nerve is visualized and preserved as well as parathyroids. Finally it is
possible to perform the lobectomy. The same technique is used for both lobes. After total thyroidectomy patients usually take
a prescribed oral synthetic thyroid hormone to prevent hypothyroidism.
Near-total thyroidectomy is an operation that involves the surgical removal of both lobes except for a small amount of thyroid
tissue (i.e. less than 1.0 mL) on one or both sides in the vicinity of the recurrent laryngeal nerve entry point and the superior
parathyroid gland. This operation follows the same technique as total thyroidectomy.
Subtotal thyroidectomy, including thyroid lobectomy and isthmusectomy, is defined as a lobectomy with contralateral subtotal
resection leaving 3 g to 5 g of normal remnant tissue on the less affected side following the same technique as described
above (Barczynski 2010). Thyroid hormonal release is maintained.
The Dunhill procedure consists of unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe
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resection leaving a thyroid stump of approximately 2 g of normal remnant tissue.
Adverse effects of the interventions
The most frequent complications of total thyroidectomy and subtotal thyroidectomy are transient or permanent
hypocalcaemia and recurrent nerve palsy. Hypocalcaemia is caused by the unintentional excision of the parathyroid glands
or by devascularization of the parathyroid glands during the surgical manoeuvres. Rates of postprocedural hypocalcaemia
are approximately 5%, resolving in 80% of cases within approximately 12 months. Transient or permanent recurrent nerve
palsy occurs due to a traumatised inferior laryngeal nerve. A wide spectrum of injuries to the voice, swallowing mechanisms,
or both, can occur because of the mixed fibres contained within the nerve. A temporary or permanent voice change can
result, which can be extremely distressing to the patient. Recurrent nerve palsy, when unilateral, presents with a one-sided
paralysed vocal cord causing voice change. Bilateral nerve palsy can seriously jeopardise the breathing mechanism and
often requires the establishment of surgical airways.
The incidence of recurrent goitre after bilateral subtotal thyroidectomy is elevated and varies between 1.2% at a maximum
follow-up of 55 months (Ozbas 2005), to 50% at a maximum follow-up of 180 months (Ríos 2005). After a secondary
intervention for recurrent goitre, the incidence of nerve lesions and hypoparathyroidism is higher due to the difficulty in
identifying, within scar tissue, the inferior laryngeal nerves and the parathyroid glands (Lefevre 2007).
How the intervention might work
Although total thyroidectomy allows a more easy follow-up of patients and avoids relapses of disease, a good proportion of
surgeons prefer a more conservative intervention because multinodular nontoxic goitre is a benign disease. Thus the
eventual complications of total thyroidectomy may not be justified and the conservative approach may preserve endogenous
thyroid function (Yang 2009). Sub-total thyroidectomy could avoid bilateral inferior laryngeal nerve injury but some relapses
of disease are possible over time.
Why it is important to do this review
Agarwal 2008 performed a systematic review to evaluate total thyroidectomy as a surgical procedure for benign multinodular
goitre. Total thyroidectomy appeared to be a safe option in the hands of expert surgeons. Near-total thyroidectomy was
shown to be a similarly effective but safer option than total thyroidectomy. However, although subtotal thyroidectomy was
marginally safer than total thyroidectomy, it may leave undetected thyroid cancers in place. The review authors concluded
that total thyroidectomy should be the procedure of choice for the surgical management of benign multinodular goitre (
Agarwal 2008).
In their recent review on surgical treatment of endemic goitre Dralle 2011 provide several arguments in support of the use of
total thyroidectomy as the treatment of choice:
non-toxic goitres involve the entire gland;
the development of sophisticated technologies has reduced the intraoperative complications associated with total
thyroidectomy;
in many cases (33%) patients receiving subtotal thyroidectomy required completion because of detection of incidental
cancer;
ultrasonography often reveals recurrent goitres post subtotal thyroidectomies; and
hormone replacement therapy is not expensive and is generally well tolerated by patients.
However, Dralle 2011 points out several factors that need to be considered when planning surgical treatment:
the treatment of iodine insufficiency does not necessarily reverse a nodular goitre and the behaviour of the nodules over
time is difficult to predict;
to gain a high level of expertise surgeons need to 'super-specialise' which is often not sustainable worldwide; and
hormone-replacement therapy is not viable everywhere in the world.
Due to the high prevalence of multinodular non-toxic goitre, this review aims to assess the effects of total versus subtotal
thyroidectomy. Although total thyroidectomy appears to be effective, safe and convenient, clinical evidence supporting its use
is still lacking.
Objectives 
The primary objective was to assess the effects of total or near-total thyroidectomy compared to subtotal thyroidectomy for
multinodular non-toxic goitre.
Methods 
Criteria for considering studies for this review 
Types of studies 
We included randomised controlled trials (RCTs).
Types of participants 
Adult (older than 18 years) participants with non-toxic multinodular goitre were considered for inclusion.
Diagnostic criteria
The diagnostic criteria were palpable thyroid nodules or multiple solid or mixed lesions found on thyroid ultrasonography in
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an euthyroid person.
Types of interventions 
Intervention
Total thyroidectomy
Near-total thyroidectomy (unilateral or bilateral thyroid remnant < 1.0 ml) was also regarded a total thyroidectomy.
Comparator
Subtotal thyroidectomy (defined as the removal of part of the gland, including thyroid lobectomy and isthmusectomy,
allowing maintenance of thyroid hormone release)
Dunhill procedure (hemithyroidectomy plus subtotal resection: unilateral thyroid remnant of 2 ml to 4 ml) is also
regarded a subtotal thyroidectomy.
Types of outcome measures 
Primary outcomes
The primary outcomes include:
All-cause mortality.
Goitre recurrence and re-intervention due to goitre recurrence.
Adverse events.
Secondary outcomes
The secondary outcomes include:
Thyroid cancer incidence.
Health-related quality of life.
Socioeconomic effects.
Method and timing of outcome measurement
All-cause mortality: defined as any postoperative death and measured 30 days postoperatively.
Goitre recurrence: defined as the presence of nodular involvement or an enlargement of the residual thyroid remnant.
Re-intervention due to goitre recurrence: defined as completion thyroidectomy for goitre recurrence.
Adverse events included the following.
Postoperative bleeding: defined as any postoperative bleeding; minor bleeding defined as development of small,
superficial wound haematoma or bruising not requiring intervention; or major bleeding defined as bleeding requiring
intervention. All bleeding outcomes were measured 30 days postoperatively.
Red cell transfusions: defined as any red cell transfused after thyroidectomy and measured 30 days postoperatively.
Permanent or transient recurrent laryngeal nerve (RLN) palsy: transient was defined as RLN palsy during indirect
laryngoscopy performed by a throat specialist and measured 30 days postoperatively; permanent RLN palsy: was
defined as a vocal cord paresis for more than 12 months after the operation.
Permanent or transient hypoparathyroidism: this could be defined by hypocalcaemia (i.e. a total serum calcium level
less than 2.0 mmol/L in either asymptomatic or symptomatic patients), perioral or fingertip paraesthesia or numbness,
tetany, or a newly positive Chvostek sign. These outcomes were measured 12, 24, 48, and 72 hours postoperatively.
Persistent hypocalcaemia for more than six months after the operation was regarded as permanent
hypoparathyroidism.
Thyroid cancer incidence: defined as an unsuspected cancer identified incidentally on pathologic examination of thyroid
tissue postoperatively.
Health-related quality of life: measured by a validated instrument such as the Medical Outcomes Study Short Form Survey
(SF-36) and measured 30 days postoperatively.
Socioeconomic effects: defined as socioeconomic costs of complications and measured at 6 and 12 months after surgery.
'Summary of findings' table
We present a 'Summary of findings' table' reporting the following outcomes based on priority:
All-cause mortality.
Goitre recurrence and re-intervention due to goitre recurrence.
Adverse events (especially recurrent laryngeal nerve injury).
Thyroid cancer incidence.
Health-related quality of life.
Socioeconomic effects.
Search methods for identification of studies 
Electronic searches 
We searched the following sources from inception of each database to the specified date:
Cochrane Library (18 June 2015):
Cochrane Central Register of Controlled Trials (CENTRAL, issue 5, May 2015)
Database of Abstracts of Reviews of Effects (DARE, issue 2, April 2015)
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Health Technology Assessment (HTA, issue 2, April 2015)
Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) (1946 to Present, 18 June 2015).
PubMed (only subsets not available on Ovid, 18 June 2015)
EMBASE (1974 to 2015 Week 24, 18 June 2015)
ClinicalTrials.gov. (18 June 2015)
World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) Search Protal (
http://apps.who.int/trialsearch/), which is a meta-register of trials with links to several trial registers,
Australian New Zealand Clinical Trials Registry (15 June 2015).
Chinese Clinical Trial Registry (15 June 2015).
ClinicalTrials.gov (15 June 2015).
EU Clinical Trials Register (EU-CTR, 4 May 2015).
ISRCTN (15 June 2015).
The Netherlands National Trial Register (15 June 2015).
Brazilian Clinical Trials Registry (ReBec, 26 May 2015).
Clinical Trials Registry - India (26 May 2015).
Clinical Research Information Service - Republic of Korea (26 May 2015).
Cuban Public Registry of Clinical Trials (26 May 2015).
German Clinical Trials Register (1 June 2015).
Iranian Registry of Clinical Trials (26 May 2015).
Japan Primary Registries Network (26 May 2015).
Pan African Clinical Trial Registry (26 May 2015).
Sri Lanka Clinical Trials Registry (1 June 2015).
Thai Clinical Trials Register (TCTR, 26 May 2015).
Detailed search strategies are reported in Appendix 1. We utilized a MEDLINE via Ovid SP email alert service for
identification of newly published studies using the search strategy detailed in Appendix 1. If we identified new studies for
inclusion we would have evaluated these and incorporated the findings in our review before submission of the final review
draft (Beller 2013).
Searching other resources 
We tried to identify other potentially eligible trials or ancillary publications by searching the reference lists of included trials,
systematic reviews, meta-analyses, review articles and health technology assessment reports.
Data collection and analysis 
Selection of studies 
Two review authors (RC, GD) independently scanned the abstract, title or both sections of every record retrieved to identify
studies for further assessment. A third party (AS) resolved any differences in opinion. If resolving disagreement was not
possible, we planned to add the article to those 'awaiting assessment' and would have contacted study authors for
clarification. We present a PRISMA (i.e. preferred reporting items for systematic reviews and meta-analyses) flow-chart to
document study selection (Liberati 2009).
Data extraction and management 
For the studies that fulfilled the inclusion criteria, two review authors (RC, GDR) independently extracted key participant and
intervention characteristics. We report data on efficacy outcomes and adverse events using standard data extraction
templates supplied by the Cochrane Metabolic and Endocrine Disorders (CMED) Group. We resolved any disagreements by
discussion, or if required, by consulting a third review author (ST). For full details see Characteristics of included studies;
additional Table 1; Appendix 2; Appendix 3; Appendix 4; Appendix 5; Appendix 6; Appendix 7; Appendix 8; Appendix 9;
Appendix 10.
We provide information about potentially-relevant ongoing studies including trial identifier in the table Characteristics of
ongoing studies and in Appendix 5 'Matrix of study endpoints (publication and trial documents)'. We tried to find the protocol
for each included study, either in databases of ongoing trials, in publications of study designs, or both, and report these data
in Appendix 5.
We sent an email request to authors of included studies to enquire whether they were willing to answer questions regarding
their trials. Appendix 11 reports the results of this survey. Thereafter if required, we sought relevant missing information on
the trial from the study authors of the article.
Dealing with duplicate publications and companion papers
In the event of duplicate publications, companion documents or multiple reports of a primary study, we maximised the yield of
information by collating all available data. In case of doubt the publication reporting the longest follow-up associated with our
primary or secondary outcomes obtained priority.
Assessment of risk of bias in included studies
Two review authors (ST, RC) independently assessed the risk of bias of each included study. We resolved disagreements by
consensus, or with consultation of a third party (MB).
We used Cochrane's 'Risk of bias' assessment tool (Higgins 2011a; Higgins 2011b), and evaluated the following criteria.
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Random sequence generation (selection bias).
Allocation concealment (selection bias).
Blinding (performance bias and detection bias), separated for blinding of participants and personnel and blinding of
outcome assessment.
Incomplete outcome data (attrition bias).
Selective reporting (reporting bias).
Other potential sources of bias.
We judged the above 'Risk of bias' criteria as either 'low', 'high', or 'unclear' risk and evaluated individual bias items as
described in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011a). We present a risk of bias
graph and a risk of bias summary. We assessed the impact of individual bias domains on study results at endpoint and study
levels.
For blinding of participants and personnel (performance bias), detection bias (blinding of outcome assessors) and attrition
bias (incomplete outcome data) we intended to evaluate risk of bias separately for subjective and objective outcomes (
Hróbjartsson 2013). We considered the implications of missing outcome data from individual participants.
We assessed outcome reporting bias by integrating the results of the Appendix 5 'Matrix of study endpoints (publication and
trial documents)' with those of the Appendix 6 'High risk of outcome reporting bias according to ORBIT classification' (
Kirkham 2010). This analysis formed the basis for the judgement of selective reporting (reporting bias).
We defined the following outcomes as subjective outcomes.
Adverse events.
Health-related quality of life.
We defined the following outcomes as objective outcomes.
All-cause mortality.
Goitre recurrence and re-intervention due to goitre recurrence.
Thyroid cancer incidence.
Socioeconomic effects.
Measures of treatment effect
We expressed dichotomous data as odds ratios (ORs) with 95% confidence intervals (CIs). We expressed continuous data
as mean differences (MD) with 95% CIs.
Unit of analysis issues 
We planned to take into account the level at which randomisation occurred, such as cross-over trials, cluster-randomised
trials and multiple observations for the same outcome.
Dealing with missing data
If feasible, we obtained relevant missing data from trial authors. We evaluated important numerical data such as the number
of screened, eligible, and randomised participants; as well as intention-to-treat (ITT), as-treated and per-protocol populations.
We investigated attrition rates including drop-outs, losses to follow-up and withdrawals. We critically appraised issues of
missing data and imputation methods (e.g. last observation carried forward).
Where standard deviations for outcomes were not reported and we did not receive information from study authors, we
planned to impute these values by assuming the standard deviation of the missing outcome to be the average of the
standard deviations from those studies where this information was reported. We planned to investigate the impact of
imputation on pooled effect estimates by means of sensitivity analysis.
Assessment of heterogeneity 
We did not pool data for meta-analysis in the event of substantial clinical, methodological or statistical heterogeneity. We
assessed heterogeneity by visual inspection of the forest plots and by calculating the Chi² test. In view of the low power of
this test an α of 0.1 was considered to be statistically significant. We also examined heterogeneity using the I² statistic, which
quantifies inconsistency across studies to assess the impact of heterogeneity on the meta-analysis (Higgins 2002; Higgins
2003). An I² statistic of 75% or more indicates a high degree of heterogeneity.
Had we found heterogeneity, we would have attempted to determine potential reasons for it by examining individual study
and subgroup characteristics.
We expected the following characteristics to introduce clinical heterogeneity.
Age.
Preoperative thyroid-stimulating hormone (TSH) levels.
Preoperative thyroid volume (assessed by ultrasound).
Surgeon's experience.
Assessment of reporting biases
Because there were fewer than 10 studies investigating a particular outcome, we did not construct a funnel plot to assess
small-study effects (Sterne 2011).
Data synthesis
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Even if there was good evidence for homogeneous effects across studies, we utilized a random-effects model because such
models are more appropriate in medical decision making contexts, especially when there are rare events (Ades 2005;
DerSimonian 1986; Fleiss 1991; Shuster 2007). We interpreted random-effects meta-analyses with due consideration of the
whole distribution of effects (Higgins 2009). In addition, we performed statistical analyses according to the statistical
guidelines described in the latest version of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011c
).
Quality of evidence
We assessed the overall quality of the body of evidence supporting each outcome using the 'Grading of Recommendations
Assessment, Development and Evaluation (GRADE)' criteria which takes into account issues related to internal (e.g. risk of
bias, inconsistency, imprecision, and publication bias) and external validity (e.g. directness of results). Two review authors
(ST, RC) independently rated the quality for each outcome. We reported a summary of the GRADE analysis in a 'Summary
of findings' table. This table provides key information about the best estimate of the magnitude of the effect, in relative terms
and absolute differences, for each relevant comparison of alternative management strategies, numbers of participants, and
studies addressing each important outcome and the rating of the overall confidence in effect estimates for each outcome. We
created the 'Summary of findings' table based on the methods described in the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011c). We reported results for the outcomes described in the Types of outcome measures section.
If meta-analysis was not possible, we reported results in a narrative 'Summary of findings' table.
Subgroup analysis and investigation of heterogeneity 
We planned to carry out the following subgroup analyses with investigation of interactions:
Treatment volume: low volume (defined as less than 50 thyroid operations per year) versus high volume (defined as 50 or
more thyroid operations per year).
Residents in general surgery versus surgeons.
Participants aged less than 75 years versus 75 years or older.
Participants with a body mass index less than 35 kg/m² versus body mass index greater than 40 kg/m².
Thyroidectomy with tie and clamp versus Ultracision or Ligasure.
However, there were not enough data to carry out these analyses.
Sensitivity analysis
We intended to perform sensitivity analyses in order to explore the influence of the following factors on effect size.
Published studies.
Taking into account risk of bias, as specified in the 'Assessment of risk of bias in included studies' section.
Very long or large studies to establish the extent to which they dominate the results.
Studies using the following filters: diagnostic criteria, imputation, language of publication, source of funding (industry
versus other), or country.
However, there were too few studies to do so.
We also planned to test the robustness of the results by repeating the analysis using different measures of effect size (RR,
OR, etc.) and different statistical models (fixed-effect and random-effects models).
Results 
Description of studies 
For a detailed description of studies, see the 'Characteristics of included studies', 'Characteristics of excluded studies, and '
Characteristics of ongoing studies' sections.
Results of the search
Our comprehensive literature searches identified a total of 1430 records. There were 1173 records after de-duplication. From
these, 14 full-text papers were identified for further examination. We excluded the other publications on the basis of titles or
abstracts because inclusion criteria were not met or because the studies were not relevant to the review objectives. See
Figure 1 for the amended PRISMA study flow diagram. After screening the full-text of the selected publications, four studies
(four publications) met the inclusion criteria. All studies were published in English.
Included studies
A detailed description of the characteristics of the included studies is presented elsewhere (see Characteristics of included
studies and appendices). The following is a succinct overview:
Source of data
Using the literature search strategy 1430 publications were identified: 504 in MEDLINE (via OVID), 57 in PubMed (subsets
not available on OVID), 106 in the Cochrane Library, 734 in EMBASE, 13 in the WHO ICTRP and 16 in ClinicalTrials.gov.
Comparisons
One study compared total to subtotal thyroidectomy (Pappalardo 1998). Two studies compared total or near-total
thyroidectomy to subtotal thyroidectomy (Giles 2004; Yang 2009), and one study compared total thyroidectomy to the Dunhill
procedure or subtotal thyroidectomy (Barczynski 2010).
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Overview of study populations
A total of 1305 participants were included in the four trials, 543 participants were randomised to total or near-total
thyroidectomy and 762 to subtotal thyroidectomy. A total of 534 (98%) participants finished the study in the total or near-total
thyroidectomy group compared to 741 (97%) participants in the subtotal thyroidectomy group. The individual sample size of
randomised participants ranged from 141 (Pappalardo 1998) to 600 (Barczynski 2010)
Study design
Studies were randomised controlled trials. All four trials utilized a parallel group superiority design. One trial was multicentric
(Yang 2009). In terms of blinding, none of the trials was double-blinded for participants and personnel. No information about
blinding of outcome assessors was available. Studies were performed between the years 1975 and 2006. The median
duration of follow-up ranged from 3 to 14.5 years (Pappalardo 1998). No trials were terminated early.
Settings
All studies were conducted in academic hospitals. No study was performed in an outpatient setting.
Participants
The participating population consisted of the following: all trials included participants from economically developed countries,
which recruited participants from China, Italy, Poland, Turkey and the USA. Surgical procedures were most commonly
performed in women. The mean (standard deviation) age of participants in the trials ranged from 46.5 (14.1) to 50.3 (12.5)
years in participants undergoing total thyroidectomy compared to 45.7 (15.6) to 48.2 (15.4) years in participants undergoing
subtotal thyroidectomy. Body mass index (BMI) was not reported. Criteria for entry into the individual studies are described in
the Characteristics of included studies tables. Major exclusion criteria were Grave's disease, Plummer disease, thyroiditis,
hyperfunctioning single adenoma or cancer.
Diagnosis
Multinodular non-toxic goitre was diagnosed with ultrasonographic examinations and thyroid function tests. One trial did not
report diagnostic procedures (Pappalardo 1998).
Interventions
Total thyroidectomy or near-total thyroidectomy was compared to subtotal thyroidectomy or the Dunhill procedure or partial
thyroidectomy.
Outcomes
Only Barczynski 2010 explicitly stated primary and secondary endpoints in the publication. The defined primary outcomes
were recurrent goitre and the need for a redo surgery.
Excluded studies
Ten studies had to be excluded after careful evaluation of the full publication - see Figure 1. The main reasons for exclusion
were: not a randomised controlled trial, Grave's disease and wrong intervention or control group (for details see
Characteristics of excluded studies).
Risk of bias in included studies 
For details on risk of bias of included studies see Characteristics of included studies. For an overview of review authors'
judgments about each risk of bias item for individual studies and across all studies see Figure 2 and Figure 3. We
investigated performance bias, detection bias and attrition bias separately for objective and subjective outcome measures.
Allocation (selection bias)
Two studies utilized adequate methods for random sequence generation and were rated as low risk of bias ( Barczynski
2010; Giles 2004). None of the studies described the method of allocation concealment.
Blinding (performance bias and detection bias)
Only one study explicitly reported that blinding of the participants and personnel was undertaken (Barczynski 2010). However
the methods used to achieve blinding were not described (Barczynski 2010). No study provided information about blinding of
outcome assessors.
Incomplete outcome data (attrition bias)
The numbers of participants discontinuing the trial were described in two publications (Barczynski 2010; Pappalardo 1998)
which had losses to follow-up of 30 and no participants, respectively. No publication mentioned the use of an intention-to-
treat analysis. Two studies did not clearly report losses to follow-up (Giles 2004; Yang 2009). Detailed descriptions of
participants' withdrawals or reasons underpinning them were not provided in all of the included studies. No trial had attrition
rates that would have a probable impact on the effect estimates.
Selective reporting (reporting bias)
According to the Outcome Reporting Bias In Trials (ORBIT) classification all included studies had a high risk of bias for
certain outcomes (for details see Appendix 6).
Other potential sources of bias
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We did not detect any other additional risk of bias.
Effects of interventions 
Baseline characteristics
For details of baseline characteristics, see Appendix 3 and Appendix 4.
We investigated the effects of total and near-total thyroidectomy versus subtotal thyroidectomy and evaluated the following
outcomes:
Primary outcomes
All-cause mortality
No postoperative hospital deaths or deaths within the first 30 days occurred after total or subtotal thyroidectomy (Analysis 1.1
). However, all-cause mortality was not measured over longer periods of follow-up in any of the included trials indicating a
high risk of reporting bias (moderate quality evidence, see Appendix 6).
Goitre recurrence and re-intervention due to goitre recurrence.
Goitre recurrence was lower in the total thyroidectomy group (OR 0.05 (95% CI 0.01 to 0.21); P < 0.0001; 1057 participants;
3 trials; moderate quality evidence; Analysis 1.2).
Re-intervention due to goitre recurrence, which was only mentioned in one included trial, was lower in the total thyroidectomy
group than in the subtotal thyroidectomy group (OR 0.66 (95% CI 0.07 to 6.38); P = 0.72; 570 participants; 1 trial; low quality
evidence; Analysis 1.3). There was a high risk of outcome reporting bias for three of four trials (Giles 2004; Pappalardo 1998;
Yang 2009).
Adverse events
The total number of adverse events were lower in the subtotal thyroidectomy group (OR 1.85 (95% CI 1.17 to 2.92); P =
0.009; 1267 participants; 4 trials; Analysis 1.4).
Postoperative bleeding and red cell transfusions
These outcomes were not evaluated in any of the analysed trials.
Permanent recurrent laryngeal nerve (RLN) palsy
The incidence of permanent RLN palsy was lower in the subtotal thyroidectomy group (OR 1.28 (95% CI 0.38 to 4.36); P =
0.69; 1275 participants; 4 trials; low quality evidence; Analysis 1.5).
Transient RLNpalsy 
The incidence of transient RLN palsy was lower in the subtotal thyroidectomy group (OR 1.62 (95% CI 0.94 to 2.78); P =
0.08; 1275 participants; 4 trials; Analysis 1.6).
Permanent hypoparathyroidism
The incidence of permanent hypoparathyroidism was lower in the subtotal thyroidectomy group (OR 3.09 (95% CI 0.45 to
21.36); P = 0.25; 1272 participants; 4 trials; low quality evidence; Analysis 1.7).
Transient hypoparathyroidism
The incidence of transient hypoparathyroidism was lower in the subtotal thyroidectomy group (OR 2.47 (95% CI 1.57 to
3.88); P < 0.0001; 1275 participants; 4 trials; Analysis 1.8).
Secondary outcomes
Thyroid cancer incidence
The incidence of thyroid cancer was less in the subtotal thyroidectomy group (OR 1.32 (95% CI 0.81 to 2.15); P = 0.27; 1134
participants; 3 trials; low quality evidence; Analysis 1.9).
Health-related quality of life
Health-related quality of life was not measured in any trial.
Socioeconomic effects
Socioeconomic effects were not evaluated in any trial.
Subgroup analyses
We did not perform subgroups analyses because there were not enough studies to estimate effects in various subgroups.
Sensitivity analyses
We performed sensitivity analyses by examining each outcome using fixed-effect and random-effects models. There were no
substantial differences in the results between models. Similarly, we examined how varying the effect size statistic using odds
ratio or relative risk influenced study outcomes. We also found no substantial differences between effect size measures.
Assessment of reporting bias
We did not construct funnel plots due to limited number of studies per outcome.
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Discussion 
Summary of main results
A systematic review of the literature identified four RCTs comparing total or near-total thyroidectomy to subtotal
thyroidectomy for the surgical management of non-toxic multinodular goitre (Barczynski 2010; Giles 2004; Pappalardo 1998;
Yang 2009). The four trials showed some heterogeneity in surgical approaches. For the purpose of this review participants
undergoing total and near-total thyroidectomy were summarised in the intervention group and participants undergoing
subtotal, partial or Dunhill thyroidectomy were classified in the comparator group.
Our key outcome measures health-related quality of life and socioeconomic effects were not adequately addressed in the
included trials. Also, postoperative bleeding and the need for transfusion were not reported. There were no deaths in the
short-term postoperative period up to 30 days after surgery. Goiter recurrence was higher for subtotal thyroidectomy. Thyroid
cancer incidence and the most important adverse effects (permanent recurrent laryngeal nerve palsy and permanent
hypoparathyroidism) did not differ substantially when comparing intervention with control groups. Two of the trials had only a
short follow-up period, which must be taken into consideration especially regarding goitre recurrence rates and potential
surgical re-interventions (Giles 2004; Yang 2009).
Overall completeness and applicability of evidence
The four included trials reported on most of our primary outcomes. Only one trial provided data on re-interventions due to
goitre recurrence (Barczynski 2010). As a caveat, there was some heterogeneity regarding the surgical techniques used by
the different study authors: near-total, subtotal, partial and Dunhill thyroidectomies can be subjectively interpreted and are
operator dependent.
Quality of the evidence
In the postoperative period no deaths were observed. However, information on all-cause mortality for longer follow-up
periods is missing which was a reason to downgrade the quality of the evidence to moderate in the Summary of findings
table 1. The data on goitre recurrence were of moderate quality due to the small number of events and an unknown risk of
detection bias. The body of evidence supporting all other key outcomes including re-intervention due to goitre recurrence,
main adverse events and thyroid cancer incidence was low quality, mainly because of high risk of outcome reporting bias
and serious imprecision (i.e. very sparse data).
Potential biases in the review process
Despite extensive search efforts we might have overlooked unpublished data especially regarding the Chinese literature.
Information such as the experience of the surgeon performing the thyroidectomy would have been essential for the
interpretation of the results but was not available.
Agreements and disagreements with other studies or reviews
Recently, a systematic review assessing the use of total thyroidectomy (including near-total thyroidectomy) compared to
subtotal thyroidectomy for the surgical management of multinodular goitre was reported (Cao 2014). The authors included a
mixture of seven observational and controlled clinical studies, comprising 2192 participants. Total thyroidectomy was
associated with lower nodule recurrence rates (OR 0.13 (95% CI 0.07 to 0.22); P < 0.001; 1927 participants; 6 trials) and
higher transient hypoparathyroidism rates (OR 2.33 (95% CI 1.72 to 3.17); P < 0.0001; 2145 participants; 7 trials) which was
comparable with our results. The OR for permanent RLN palsy was 0.81 (95% CI 0.24 to 2.74); P = 0.74; 2145 participants;
7 trials) and the OR for permanent hypothyroidism was 2.94 (95% CI 0.48 to 18.11); P = 0.24; 2145 participants; 7 trials).
These results were compared to our own results.
Authors' conclusions 
Implications for practice 
The body of evidence on (near) total thyroidectomy compared with subtotal thyroidectomy is limited. Moderate quality
evidence indicates that there are no substantial differences between these surgical techniques on postoperative deaths up to
30 days after surgery. Goiter recurrence is reduced following (near) total thyroidectomy which has to be interpreted with
caution due to unknown risk of detection bias and the small number of events overall. The other findings of our review could
only partially address our objectives, mainly because information on re-interventions due to goitre recurrence, adverse
events and thyroid cancer incidence was limited.
Implications for research 
Longer follow-up periods were only provided in two trials which limits the body of evidence especially for the incidence of
goitre recurrence. None of the considered trials described data on all-cause mortality over longer follow-up periods, health-
related quality of life or socioeconomic effects of the two interventions. Subgroup analyses would have been vital for the
completeness of this review but data were not reported: the treatment volume of the surgical centres, participants age,
participants body mass index, the technique used to divide vessels and the surgeons level of experience may play an
important role in postoperative outcomes. New trials reporting on these aspects are required.
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Characteristics of studies
Characteristics of included studies 
Barczynski 2010
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Methods Parallel RCT, superiority design
 
Participants Inclusion criteria: bilateral non-toxic MNG with the posterior aspects of both thyroid
lobes appearing normal on ultrasound of the neck
Exclusion criteria: MNG involving the posterior aspect/s of thyroid lobe/s, suspicion of
thyroid cancer, previous thyroid surgery, thyroiditis, subclinical or clinically overt
hypothyroidism or hyperthyroidism, pregnancy or lactation, age < 18 years or > 65
years, American Society of Anesthesiology (ASA) grade 4, and a participant’s inability
to comply with the follow-up protocol
Diagnostic criteria: high-resolution doppler ultrasound of the neck. Fine needle
aspiration of the thyroid. Serum free T3, free T4 and thyroid-stimulating hormone
(TSH); thyroid peroxidase antibodies levels
 
Interventions Number of study centres: 1
Treatment before study: not reported
 
Outcomes Outcomes reported in abstract of publication: 
Primary outcome: prevalence of recurrent goitre and need for redo surgery
Secondary outcome: postoperative morbidity rate (hypoparathyroidism and recurrent
laryngeal nerve injury)
 
Study details Run-in period: none
Study terminated before regular end (for benefit / because of adverse events): no
 
Publication details Language of publication: English
Non-commercial funding
Publication status: peer-reviewed journal
 
Stated aim of study Quote from publication: "The aim of the present study was to evaluate results of
various thyroid resection modes (Total Thyroidectomy versus Dunhill Operation versus
Bilateral Subtotal Thyroidectomy), with special emphasis put on the recurrence rate
and morbidity rate, in a 5-year follow-up"
 
Notes -
 
Risk of bias table
T100720 Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
14 / 39
Bias Authors'judgement Support for judgement
Random sequence generation
(selection bias)
Low risk Quote from publication: "Randomization was performed by computer-
generated permuted block sequencing"
Comment: unclear block size
 
Allocation concealment (selection
bias)
Unclear risk Quote from publication: "Patients allocated by opening sealed envelopes
in the operating theatre"
Comment: questionable whether envelopes were opaque and sequentially
numbered
 
Blinding of participants and
personnel (performance bias)
Objective outcomes
Low risk Quote from publication: "All participants were blinded to treatment
assignment for the duration of the study"
Comment: no information about personnel blinding provided but we judge
that the objective outcomes of this review are not likely to be influenced by
lack of blinding of participants or personnel
 
Blinding of participants and
personnel (performance bias)
Subjective outcomes
Unclear risk Comment: unclear whether adverse events were measured by study
personnel (potential risk of bias)
 
Blinding of outcome assessment
(detection bias)
Objective outcomes
Unclear risk Comment: no information
 
Blinding of outcome assessment
(detection bias)
Subjective outcomes
Unclear risk Comment: no information
 
Incomplete outcome data (attrition
bias)
Objective outcomes
Low risk Comment: during follow-up a total of 30 participants were lost to follow-up,
the reasons are not provided in the publication but the number of
participants lost to follow-up is balanced among treatment arms; it is
unlikely that the low attrition rate affected outcome measures
 
Incomplete outcome data (attrition
bias)
Subjective outcomes
Low risk Comment: during follow-up a total of 30 participants were lost to follow-up,
the reasons are not provided in the publication but the number of
participants lost to follow-up is balanced among treatment arms; it is
unlikely that the low attrition rate affected outcome measures
 
Selective reporting (reporting bias) High risk Comment: high risk of bias for outcome measure all-cause mortality
according to the ORBIT classification (see Appendix 6)
 
Other bias Low risk Comment: none detected
 
Giles 2004
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Methods Parallel RCT, superiority design
 
Participants Inclusion criteria: nontoxic MNG
Exclusion criteria: no history of hyperthyroidism, radiation exposure, familial thyroid
cancer, preoperative or perioperative suspicion of cancer
Diagnostic criteria: ultrasonography examination (multinodular hyperplasia of the
thyroid gland)
 
Interventions Number of study centres: 1
Treatment before study: not reported
 
Outcomes Outcomes reported in abstract of publication: transient recurrent laryngeal nerve
paralysis, transient hypocalcaemia symptoms, permanent recurrent laryngeal nerve
paralysis, permanent hypoparathyroidism, papillary cancer, goitre recurrence,
reoperation or radioactive iodine ablation for goitre recurrence
 
Study details Run-in period: none
Study terminated before regular end (for benefit / because of adverse events): no
 
Publication details Language of publication: English
Non-commercial funding
Publication status: peer-reviewed journal
 
Stated aim of study Quote from publication: "To investigate the impact of total thyroidectomy on the rate of
completion thyroidectomy for incidentally found thyroid cancer in euthyroid multinodular
goiter"
 
Notes -
 
Risk of bias table
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Bias Authors'judgement Support for judgement
Random sequence generation
(selection bias)
Low risk Quote from publication: "Patients were selected according to the number
on the random table for 2 different extensions of surgical procedures"
 
Allocation concealment (selection
bias)
Unclear risk Comment: information about allocation concealment not provided
 
Blinding of participants and
personnel (performance bias)
Objective outcomes
Unclear risk Comment: information about blinding of personnel and participants not
provided
 
Blinding of participants and
personnel (performance bias)
Subjective outcomes
Unclear risk Comment: information about blinding of personnel and participants not
provided
 
Blinding of outcome assessment
(detection bias)
Objective outcomes
Unclear risk Comment: information about blinding of outcome assessment not
provided
 
Blinding of outcome assessment
(detection bias)
Subjective outcomes
Unclear risk Comment: information about blinding of outcome assessment not
provided
 
Incomplete outcome data (attrition
bias)
Objective outcomes
Low risk Comment: no drop-outs
 
Incomplete outcome data (attrition
bias)
Subjective outcomes
Low risk Comment: no drop-outs
 
Selective reporting (reporting bias) High risk Comment: high risk of bias for outcome measures all-cause mortality
and re-intervention due to goitre recurrence according to the ORBIT
classification (see Appendix 6)
 
Other bias Low risk Comment: none detected
 
Pappalardo 1998
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Methods Parallel RCT, superiority design
 
Participants Inclusion criteria: unilateral and bilateral multinodular euthyroid goitres
Exclusion criteria: graves' disease, Plummer disease, thyroiditis, hyperfunctioning
single adenoma or cancer
Diagnostic criteria: not reported
 
Interventions Number of study centres: 1
Treatment before study: not reported
 
Outcomes Outcomes reported in abstract of publication: temporary or permanent palsy of the
recurrent laryngeal nerve, temporary or permanent hypoparathyroidism, recurrence of
the goitre, and the incidence of iatrogenic injuries after completion thyroidectomy
 
Study details Run-in period: none
Study terminated before regular end: no
 
Publication details Language of publication: English
Non-commercial funding
Publication status: peer-reviewed journal
 
Stated aim of study Quote from publication: "To evaluate the outcome after total and subtotal
thyroidectomy for the treatment of single and multinodular goitres in two comparable
groups of patients"
 
Notes -
 
Risk of bias table
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Bias Authors'judgement Support for judgement
Random sequence generation
(selection bias)
Unclear risk Quote from publication: "The patients were randomly assigned to have
total thyroidectomy or subtotal thyroidectomy"
Comment: the procedure to perform randomisation is not described
 
Allocation concealment (selection
bias)
Unclear risk Comment: information about allocation concealment not provided
 
Blinding of participants and
personnel (performance bias)
Objective outcomes
Unclear risk Comment: information about blinding of participants and personnel not
provided
 
Blinding of participants and
personnel (performance bias)
Subjective outcomes
Unclear risk
Comment: information about blinding of participants and personnel not
provided
 
Blinding of outcome assessment
(detection bias)
Objective outcomes
Unclear risk Comment: information about blinding of outcome assessment not
provided
 
Blinding of outcome assessment
(detection bias)
Subjective outcomes
Unclear risk Comment: information about blinding of participants and personnel not
provided
 
Incomplete outcome data (attrition
bias)
Objective outcomes
Low risk Comment: no missing outcome data, all participants completed the
follow-up
 
Incomplete outcome data (attrition
bias)
Subjective outcomes
Low risk Comment: no missing outcome data, all participants completed the
follow-up
 
Selective reporting (reporting bias) High risk Comment: high risk of bias for outcome measures all-cause mortality
and re-intervention due to goitre recurrence according to the ORBIT
classification (see Appendix 6)
 
Other bias Low risk Comment: none detected
 
Yang 2009
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Methods Parallel RCT, superiority design
 
Participants Inclusion criteria: bilateral multinodular goitre
Exclusion criteria: no history of thyroidectomy
Diagnostic criteria: ultrasonography examination (a bilateral multinodular goitre)
 
Interventions Number of study centres: 1
Treatment before study: not reported
 
Outcomes Outcomes reported in abstract of publication: transient recurrent laryngeal nerve
paralysis, transient hypocalcaemia symptoms, permanent hypoparathyroidism, goitre
recurrence
 
Study details Run-in period: none
Study terminated before regular end (for benefit / because of adverse events): no
 
Publication details Language of publication: English
Non-commercial funding
Publication status: peer-reviewed journal
 
Stated aim of study "To evaluate the feasibility and safety of total and near-total bilateral thyroidectomy for
the treatment of bilateral multinodular goiter."
 
Notes -
 
Risk of bias table
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Bias Authors'judgement Support for judgement
Random sequence generation
(selection bias)
Unclear risk Quote from publication: "... patients with a diagnosis of bilateral
multinodular goiter were randomly divided into two groups .."
Comment: the procedure to perform randomisation is not described
 
Allocation concealment (selection
bias)
Unclear risk Comment: information about allocation concealment not provided
 
Blinding of participants and
personnel (performance bias)
Objective outcomes
Unclear risk Comment: information about blinding of participants and personnel not
provided
 
Blinding of participants and
personnel (performance bias)
Subjective outcomes
Unclear risk Comment: information about blinding of participants and personnel not
provided
 
Blinding of outcome assessment
(detection bias)
Objective outcomes
Unclear risk Comment: information about blinding of outcome assessment not
provided
 
Blinding of outcome assessment
(detection bias)
Subjective outcomes
Unclear risk Comment: information about blinding of outcome assessment not
provided
 
Incomplete outcome data (attrition
bias)
Objective outcomes
Low risk Comment: no drop-outs
 
Incomplete outcome data (attrition
bias)
Subjective outcomes
Low risk Comment: no drop-outs
 
Selective reporting (reporting bias) High risk Comment: high risk of bias for outcome measures all-cause mortality
and re-intervention due to goitre recurrence according to the ORBIT
classification (see Appendix 6)
 
Other bias Low risk Comment: none detected
 
Footnotes
ASA: American Society of Anesthesiology; MNG: multinodular nontoxic goitre; ORBIT: Outcome Reporting Bias In Trials;
RCT: randomised controlled trial
Characteristics of excluded studies 
Barczynski 2012
Reason for exclusion In this RCT bilateral subtotal thyroidectomy is compared with total thyroidectomy for
the surgical management of Grave's disease
 
Chi 2005
Reason for exclusion In this RCT bilateral subtotal thyroidectomy is compared with hemithyroidectomy plus
subtotal resection (Dunhill procedure) for the surgical management of Grave's disease
 
Erbil 2006
Reason for exclusion In this RCT total thyroidectomy is compared with near-total thyroidectomy for the
surgical management of multinodular goitre
 
Rayes 2013
Reason for exclusion In this RCT bilateral subtotal thyroidectomy is compared with hemithyroidectomy plus
subtotal resection (Dunhill procedure) for the surgical management of bilateral
multinodular goitre
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Rouwen 2011
Reason for exclusion A systematic review on surgical approach for treating multinodular goitre: total
thyroidectomy/near- total thyroidectomy with subtotal thyroidectomy/bilateral subtotal
thyroidectomy/Dunhill procedure
 
Sancho 2012
Reason for exclusion In this RCT hemithyroidectomy is compared with hemithyroidectomy plus subtotal
resection (Dunhill procedure) for the surgical management of asymmetrical
multinodular goitre
 
Tezelman 2009
Reason for exclusion A retrospective cohort study comparing subtotal versus near-total or total
thyroidectomy in the treatment of patients with multinodular goitre
 
Unalp 2009
Reason for exclusion In this RCT total thyroidectomy is compared with near-total thyroidectomy for the
surgical management of multinodular goitre
 
Vaiman 2008
Reason for exclusion A retrospective cohort study comparing subtotal versus near-total thyroidectomy in the
treatment of patients with multinodular goitre
 
Witte 2000
Reason for exclusion In this RCT total thyroidectomy is compared with subtotal resection for the surgical
management of Grave's disease
 
Footnotes
RCT: randomised controlled trial
Characteristics of studies awaiting classification 
Footnotes
Characteristics of ongoing studies 
Footnotes
Summary of findings tables
1 Total or near-total thyroidectomy compared with subtotal thyroidectomy for multinodular non-toxic goitre in
adults
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Total or near-total thyroidectomy compared with subtotal thyroidectomy for multinodular non-toxic goitre in adults
Patient: adults with multinodular non-toxic goitre
Settings: tertiary referral centre
Intervention: (near) total thyroidectomy
Comparison: subtotal thyroidectomy
Outcomes Illustrative comparative risks*
(95% CI)
Relative
effect
(95% CI)
No of
participants
(studies)
Quality of
the evidence
(GRADE)
Comments
Assumed risk Corresponding
risk
Subtotal
thyroidectomy
(Near)total
thyroidectomy
All-cause mortality
Follow-up: 1 to 10
years
See comment See comment See
comment
1284 (4) a) ⊕⊕⊕⊝
moderatea
No postoperative hospital
deaths or deaths within the
first 30 days occurred after
total or subtotal
thyroidectomy
a) Goitre recurrence 
b) Re-intervention due
to goitre recurrence
Follow-up: a) 3 to 10
years, b) 5 years
a) 84 per 1000
b) 8 per 1000
a) 5 per 1000 (1
to 19)
b) 5 per 1000 (1
to 48)
a) OR 0.05
(0.01 to
0.21)
b) OR 0.66
(0.07 to
6.38)
a) 1057 (3)
b) 570 (1)
a) ⊕⊕⊕⊝
moderateb
b) ⊕⊕⊝⊝
lowc
-
Adverse events:
a) Permanent recurrent
laryngeal nerve palsy
b) Permanent
hypoparathyroidism
Follow-up: a) 1 to 10
years, b) 1 to 10 years
a) 8 per 1000
b) 1 per 1000
a) 10 per 1000
(3 to 34)
b) 4 per 1000 (1
to 28)
a) OR 1.28
(0.38 to
4.36)
b) OR 3.09
(0.45 to
21.36)
a) 1275 (4)
b) 1275 (4)
a)
⊕⊕⊝⊝
lowd
b)
⊕⊕⊝⊝
lowd
-
Thyroid cancer
incidence
Follow-up: 1 to 5 years
61 per 1000 79 per 1000 (50
to 123)
OR 1.32
(0.81 to
2.15)
1134 (3) ⊕⊕⊝⊝
lowd
-
Health-related quality
of life
See comment See comment See
comment
See
comment
See
comment
Outcome not investigated
Socioeconomic effects See comment See comment See
comment
See
comment
See
comment
Outcome not investigated
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The
corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative
effect of the intervention (and its 95% CI).
CI: confidence interval; OR: odds ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may
change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is
likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
Footnotes
Assumed risk: mean control group risk across studies
aDowngraded by one level because of high risk of outcome reporting bias (no trial investigated all-cause mortality over longer
periods of follow-up)
bDowngraded by one level because of small number of events and unknown risk of detection bias
cDowngraded by two levels because of high risk of outcome reporting bias (3 of 4 trials did not report re-interventions due to
goitre recurrence), imprecision and one study only with small number of participants and low event rates
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dDowngraded by two levels because of imprecision and low event rates
Additional tables 
1 Overview of study populations
  Intervention(s) and
comparator(s)
Sample
sizea
Screened/eligible
[N]
Randomised
[N]
Safety
[N]
ITT
[N]
Finishing
study
[N]
Randomised
finishing study
[%]
Follow-up
time
(1)
Barczynski
2010
I: total
thyroidectomy
b 3133 200 200 - 191 95 5 years
C1: Dunhill
procedure
200 200 - 189 94
C2: bilateral
subtotal
thyroidectomy
200 200 - 190 95
total: 600 600 - 570 95
(2) Giles
2004
I: total or near total
thyroidectomy
- - 109 109 - 109 100 1-3 years
C: subtotal
thyroidectomy
109 109 - 109 100
total: 218 218 - 218 100
(3)
Pappalardo
1998
I: total or near total
thyroidectomy
- - 69 69 - 69 100 10 years
C: bilateral subtotal
thyroidectomy
72 72 - 72 100
total: 141 141 - 141 100
(4) Yang
2009
I: total or near total
thyroidectomy
- - 165 165 - 165 100 I: median
follow-up 36
months
C: subtotal
thyroidectomy
181 181 - 181 100 C: median
follow-up 39
months
total: 346 346 - 346 100  
Grand total All interventions   543   534 98
 All c omparators 762 741 97
All interventions
and c omparators
1305 1275 98
Footnotes
aAccording to power calculation in study publication or report
bQuote from publication: "The sample size was estimated based on the principle of detecting a 5% difference in the
prevalence of recurrent goiter with a 90% probability at P < 0.05"; comment: no sample size provided
"-" denotes not reported
C: comparator; I: intervention; ITT: intention-to-treat
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Other published versions of this review 
Classification pending references
Data and analyses 
1 (Near) Total thyroidectomy versus subtotal thyroidectomy
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate
1.1 Overall post-operative mortality 4   Odds Ratio(M-H, Random, 95% CI) No totals
1.2 Goitre recurrence 3 1057 Odds Ratio(M-H, Random, 95% CI) 0.05[0.01, 0.21]
1.3 Re-intervention due to goitre
recurrence 1   Odds Ratio(M-H, Random, 95% CI) No totals
1.4 Adverse events 4 1267 Odds Ratio(M-H, Random, 95% CI) 1.85[1.17, 2.92]
1.5 Permanent recurrent laryngeal
nerve palsy 4 1275 Odds Ratio(M-H, Random, 95% CI) 1.28[0.38, 4.36]
1.6 Transient recurrent laryngeal
nerve palsy 4 1275 Odds Ratio(M-H, Random, 95% CI) 1.62[0.94, 2.78]
1.7 Permanent hypoparathyroidism 4 1275 Odds Ratio(M-H, Random, 95% CI) 3.09[0.45, 21.36]
1.8 Transient hypoparathyroidism 4 1275 Odds Ratio(M-H, Random, 95% CI) 2.47[1.57, 3.88]
1.9 Thyroid cancer incidence 3 1134 Odds Ratio(M-H, Random, 95% CI) 1.32[0.81, 2.15]
Figures
Figure 1
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Caption
Study flow diagram.
Figure 2
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Caption
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included
studies.
Figure 3
Caption
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Sources of support 
Internal sources
No sources of support provided
External sources
No sources of support provided
Feedback 
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Appendices 
1 Search strategies
Cochrane Library  (Wiley)
1. [mh ^"Goiter, Nodular"]
2. [mh ^"Thyroid Nodule"]
3. ((goiter* or goitre*) near/7 (nodul* or multinodul* or multi nodul* or "nontoxic" or "non toxic")):ti,ab,kw
4. {or #1-#3}
5. [mh ^"Thyroidectomy"]
6. thyroidectom*:ti,ab,kw
7. surg*:ti,ab,kw
8. {or #5-#7}
9. #4 and #8
MEDLINE (Ovid SP)
1. Goiter, Nodular/
2. Thyroid Nodule/
3. ((goiter* or goitre*) adj6 (nodul* or multinodul* or multi nodul* or nontoxic or non toxic)).tw.
4. or/1-3
5. Thyroidectomy/
6. thyroidectom*.tw.
7. surg*.tw.
8. or/5-7
9. 4 and 8
[10-19: Cochrane Handbook 2008 RCT filter - sensitivity maximizing version, without "drug therapy.fs."]
10. randomized controlled trial.pt.
11. controlled clinical trial.pt.
12. randomi?ed.ab.
13. placebo.ab.
14. randomly.ab.
15. trial.ab.
16. groups.ab.
17. or/10-16
18. exp animals/ not humans/
19. 17 not 18
20. 9 and 19
PubMed Search Strategy 
(only subsets not available on Ovid SP)
#1 ((goiter*[tiab] OR goitre*[tiab] OR thyroid*[tiab]) AND (nodul*[tiab] OR multinodul*[tiab] OR multi nodul*[tiab] OR
nontoxic[tiab] OR non toxic[tiab]))
#2 thyroidectom*[tiab] OR surg*[tiab]
#3 #1 AND #2
#4 random*[tiab] OR trial[tiab] OR groups[tiab]
#5 #3 AND #4
#6 #5 NOT medline[sb] NOT pmcbook
EMBASE (Ovid SP)
1. Nodular goiter/
2. Thyroid nodule/
3. ((goiter* or goitre*) adj6 (nodul* or multinodul* or multi nodul* or nontoxic or non toxic)).tw.
4. or/1-3
5. Thyroidectomy/
6. Subtotal thyroidectomy/
7. thyroidectom*.tw.
8. surg*.tw.
9. or/5-8
10. 4 and 9
[11: Wong et al. 2006 "sound treatment studies" filter – SDSSGS version] 
11. random*.tw. or clinical trial*.mp. or exp treatment outcome/
12. 10 and 11
13. limit 12 to embase
ICTRP Search Portal
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Cochrane Library  (Wiley)
Standard search:
goit* AND nodul* AND thyroidectom* OR
goit* AND nodul* AND surg* OR
goit* AND multinodul* AND thyroidectom* OR
goit* AND multinodul* AND surg* OR
goit* AND nontoxic AND thyroidectom* OR
goit* AND nontoxic AND surg* OR
goit* AND non toxic AND thyroidectom* OR
goit* AND non toxic AND surg*
ClinicalTrials.gov
Advanced Search:
Conditions: (goiter OR goitre OR goiters OR goitres) AND (multinodular OR nodular OR multinodules OR nodules OR
nontoxic OR “non toxic”)
Interventions: thyroidectomy OR thyroidectomies OR surgery OR surgical OR surgeries
Age Group: Adult + Senior
2 Description of interventions
  Intervention(s) Comparator(s)
Barczynski
2010
Total thyroidectomy (extracapsular thyroidectomy) C1: Dunhill procedure
C2: bilateral subtotal thyroidectomy
Giles 2004 Total or near-total thyroidectomy (extracapsular
thyroidectomy)
Subtotal thyroidectomy (the total amount of
remnant thyroid tissue was intended to be ≥ 5 g)
Pappalardo
1998
Total thyroidectomy (extracapsular thyroidectomy) Subtotal thyroidectomy ( leaving 3-5 g on the less
affected side)
Yang 2009 Total or near-total thyroidectomy (extracapsular-
thyroidectomy or -small remnant of thyroid tissue < 1 mg)
Subtotal thyroidectomy
Dunhill procedure: unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe resection
3 Baseline characteristics (I)
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  Intervention(s)
and
comparator(s)
Duration of
follow-up
Participating
population
Study
period
[year to
year]
CountrySetting Duration
of MNG
Barczynski
2010
I: total
thyroidectomy
5 years Bilateral nontoxic
MNG
2000 to
2003
Poland  
Department of endocrine
surgery, tertiary referral centre
-
C1: Dunhill
procedure
C2: bilateral
subtotal
thyroidectomy
Giles 2004 I: (near) total
thyroidectomy
1-3 years Multinodular
euthyroid goitre with
or without a dominant
nodule
2003 to
2005
Turkey Departments of general surgery
and endocrinology, tertiary
referral centre
-
C: subtotal
thyroidectomy
Pappalardo
1998
I: total
thyroidectomy
10 years Unilateral and
bilateral multinodular
euthyroid goitre
1975 to
1985
Italy Surgical clinic & department of
internal medicine, tertiary
referral centre
-
C: subtotal
thyroidectomy
Yang 2009 I: (near) total
thyroidectomy
 
Median
follow-up 36
months
Bilateral nontoxic
MNG
2003 to
2006
China  
Departments of general
surgery, clinical and molecular
pharmacology and pathology,
tertiary referral centre
-
C: subtotal
thyroidectomy
Median
follow-up 39
months
"-" denotes not reported
Dunhill procedure: unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe resection
C: comparator; I: intervention; MNG: multinodular nontoxic goitre
4 Baseline characteristics (II)
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  Intervention(s)
and
comparator(s)
Sex
[female
%]
Age
[mean/range
years (SD),
or as
reported]
Thyroid
volume
[mean
ml
(SD)]
Comedications/Cointerventions Comorbidities
Barczynski
2010
I: total
thyroidectomy
91 46.5(14.1) 76.6
(38.9)
All participants, irrespective of the individual group
assignment, received postoperative levothyroxine
treatment at a dose adjusted to the serum TSH
concentration to keep it within the lowest two-thirds
of the reference range (0.3–2.5 mU/L)
-
C1: Dunhill
procedure
89 47.2 (15.6) 77.8
(39.5)
C2: bilateral
subtotal
thyroidectomy
91 48.2 (15.4) 78.9
(40.1)
Giles 2004 I: (near) total
thyroidectomy
 
86
50.3 (12.5) - Suppressive doses of thyroid hormone for some
participants (e.g. patients with noninvasive
microcarcinoma without radioiodine ablation)
-
C: subtotal
thyroidectomy
 
84
45.7 (12.1)  
Pappalardo
1998
I: total
thyroidectomy
71 Mean 48 (25-
67)
- All patients were discharged taking L-thyroxine
1.5–2.25 µg/kg body weight daily; dose of L-
thyroxine was subsequently adjusted depending on
the concentration of circulating TSH; higher doses
of L-thyroxine were prescribed for patients who had
subtotal resections (TSH < 0.8 mU/L) and lower
doses to patients who had total thyroidectomy and
to older and postmenopausal patients with the risk
of iatrogenic osteoporosis
-
C: subtotal
thyroidectomy
71 Median 50
(27-70)
Yang 2009 I: (near) total
thyroidectomy
78 22-72 - Thyroxine substitution was prescribed to those with
insufficient thyroid function
-
C: subtotal
thyroidectomy
77
"-" denotes not reported
Dunhill procedure: unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe resection
C: comparator; I: intervention; SD: standard deviation; TSH: thyroid-stimulating hormone
5 Matrix of study endpoints (publications and trial documents)
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  Endpoints quoted in
trial document(s)
(ClinicalTrials.gov,
FDA/EMA document,
manufacturer's website,
published design paper)a
Study
results
posted in
trial
register
[Yes/No]
Publications
specified in
trial register
[Yes/No]
Endpoints quoted in publication(s)b,c Endpoints quoted in
abstract of publication(s)b,c
Barczynski
2010
Source: NCT00946894
Primary outcome
measure(s):
prevalence of recurrent
goiter and need for redo
surgery (time frame: at
12, 24, 36, 48 and 60
months after surgery)
No Yes Primary outcome measure(s):
prevalence of recurrent goiter and
need for redo surgery
Primary outcome
measure(s):
prevalence of recurrent
goiter and need for redo
surgery
Secondary outcome
measure(s):
postoperative morbidity
rate
(hypoparathyroidism
and recurrent laryngeal
nerve injury - time
frame: at 3, 6, 9, 12, 24,
36, 48 and 60 months
after surgery)
Secondary outcome measure(s):
postoperative morbidity rate
(hypoparathyroidism and recurrent
laryngeal nerve injury)
Secondary outcome
measure(s):
postoperative morbidity rate
(hypoparathyroidism and
recurrent laryngeal nerve
injury
Other outcome
measure(s):
-
Other outcome measure(s):
serum TSH; serum calcium level;
operative time; haemorrhage
Other outcome measure(s):
-
Giles 2004 N/T Primary outcome measure(s):
-
Primary outcome
measure(s):
-
Secondary outcome measure(s):
-
Secondary outcome
measure(s):
-
Other outcome measure(s):
postoperative complications
(permanent/temporary
hypoparathyroidism and
permanent/temporary vocal cord
paralysis); thyrotropin; serum
thyroglobulin; incidence of thyroid
cancer, difference in the rate of
thyroid cancer requiring radioactive
iodine ablation and completion
thyroidectomy; operation for benign
goitre
Other outcome measure(s):
complication rates
(permanent/temporary
hypoparathyroidism and
permanent/temporary vocal
cord paralysis); incidence of
thyroid cancer requiring
radioactive iodine ablation
and completion
thyroidectomy
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  Endpoints quoted in
trial document(s)
(ClinicalTrials.gov,
FDA/EMA document,
manufacturer's website,
published design paper)a
Study
results
posted in
trial
register
[Yes/No]
Publications
specified in
trial register
[Yes/No]
Endpoints quoted in publication(s)b,c Endpoints quoted in
abstract of publication(s)b,c
Pappalardo
1998
N/T Primary outcome measure(s):
-
Primary outcome
measure(s):
-
Secondary outcome measure(s):
-
Secondary outcome
measure(s):
-
Other outcome measure(s):
recurrence rate after subtotal
resection; serum calcium
concentrations; measurement of
parathyroid hormone;
triiodothyronine (T3), thyroxine (T4)
and TSH concentrations;
postoperative stay in hospital; rate of
injuries to the recurrent nerve;
hypothyroidism; reoperations
in the subtotal group the rate of
injuries to the recurrent nerve,
hypoparathyroidism, and
recurrences were the only variables
evaluated
Other outcome measure(s):
temporary or permanent
palsy of the recurrent
laryngeal nerve; temporary
or permanent
hypoparathyroidism;
recurrence of the goitre;
incidence of iatrogenic
injuries after completion
thyroidectomy
Yang 2009 N/T Primary outcome measure(s):
-
Primary outcome
measure(s):
-
Secondary outcome measure(s):
-
Secondary outcome
measure(s):
-
Other outcome measure(s):
serum concentrations of thyroid
hormone parameters, such as free
triiodothyronine
(FT3), free thyroxine (FT4), and
supersensitive thyroid-stimulating
hormone (TSH); vocal cord mobility,
transient/permanent recurrent
laryngeal nerve palsy; serum
calcium/hypoparathyroidism;
recurrence rate
Other outcome measure(s):
incidences of postoperative
complications and
recurrence rate; thyroid
cancer; transient recurrent
laryngeal nerve paralysis;
injury to superior laryngeal
nerve; transient
hypocalcaemia symptoms;
permanent
hypoparathyroidism;
recurrence
- denotes not reported
aTrial document(s) refers to all available information from published design papers and sources other than regular
publications (e.g. FDA/EMA documents, manufacturer's websites, trial registers)
bPublication(s) refers to trial information published in scientific journals (primary reference, duplicate publications,
companion documents or multiple reports of a primary study)
cOther outcome measures refer to all outcomes not specified as primary or secondary outcome measures
EMA: European Medicines Agency; FDA: Food and Drug Administration (US); N/T: no trial document available; TSH:
thyroid-stimulating hormone
6 High risk of outcome reporting bias according to ORBIT classification
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  Outcome High risk of bias
(category A)a
High risk of bias
(category D)b
High risk of bias
(category E)c
High risk of bias
(category G)d
Barczynski 2010 All-cause mortality       x
Giles 2004 All-cause mortality       x
Re-intervention due to goitre
recurrence
      x
Pappalardo 1998 All-cause mortality     x  
Re-intervention due to goitre
recurrence
    x  
Yang 2009 All-cause mortality   x    
Re-intervention due to goitre
recurrence
      x
aClear that outcome was measured and analysed; trial report states that outcome was analysed but only reports that result
was not significant
(Classification 'A', table 2, Kirkham 2010)
bClear that outcome was measured and analysed; trial report states that outcome was analysed but no results reported
(Classification 'D', table 2, Kirkham 2010)
cClear that outcome was measured; clear that outcome was measured but not necessarily analysed; judgement says likely
to have been analysed but not reported because of non-significant results
(Classification 'E', table 2, Kirkham 2010)
dUnclear whether the outcome was measured; not mentioned but clinical judgement says likely to have been measured and
analysed but not reported on the basis of non-significant results
(Classification 'G', table 2, Kirkham 2010)
N/A: not applicable; ORBIT: Outcome Reporting Bias In Trials
7 Definition of endpoint measurement
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  Goitre recurrence Re-intervention
due to goitre
recurrence
Transient recurrent
laryngeal nerve palsy
Transient
hypoparathyroidism
Health-
related
quality
of life
Severe/serious
adverse events
Barczynski
2010
"Presence of
hypoechoic or
hyperechoic
nodular pattern at
least 5 mm in
diameter,
identification of
perinodular
hypoechogenic or
hyperechogenic
halo, and presence
of an anechoic
lesion with a
reinforced
posterior wall"
Completion
thyroidectomy;
presence of a 3
cm or larger
nodule; result of
FNA suggestive
of an increased
risk for
malignancy; and
presence of
compressive
symptoms
Vocal cord paresis
for ≤ 12 months after
the operation;
indirect laryngoscopy
by a throat specialist
was mandatory
before surgery and
on day 2
postoperatively; in
patients with RLN
paresis, additional
examinations were
scheduled at 2
weeks and 1, 2, 4, 6,
and 12 months after
surgery, or until the
vocal cord function
recovered
Hypocalcaemia for ≤ 6
months after the
operation; patients
were monitored for
postoperative
biochemical
hypocalcaemia at 12,
24, 48, and 72 h
(during hospitalization
and after discharge on
morning outpatient
visits), with
hypocalcaemia being
defined as a total
serum calcium level
less than 2.0 mmol/L in
either asymptomatic or
symptomatic patients
(perioral or fingertip
paraesthesia or
numbness, tetany, a
newly positive
Chvostek sign)
N/I Vocal cord paresis for
more than 12 months
after the operation
was regarded as
permanent palsy.
Persistent
hypocalcaemia for
more than 6 months
after the operation
was regarded as
permanent
hypoparathyroidism
Giles 2004 N/I N/I Not explained Not explained N/I Not explained
Pappalardo
1998
Goitre recurrence
was diagnosed
"when physical
examination or
follow-up
ultrasound scan
showed nodular
involvement or an
enlargement of the
residual thyroid
remnant"
Completion
thyroidectomy
"A palsy of the vocal
cord diagnosed by
an otolaryngologist
that lasted less than
six months
postoperatively"
"A fall in the serum
calcium concentration
(less than 2.1 mmol/L)
corrected according to
the serum albumin
concentration"
N/I "Permanent injury to
the recurrent nerve
was considered as
palsy of the vocal cord
diagnosed by an
otolaryngologist that
lasted for more than
six months
postoperatively"
"Permanent
hypoparathyroidism
as the need for oral
vitamin D and calcium
six months after the
operation"
Yang 2009 "The recurrence
was defined as de
novo nodules more
than 3 mm in
remnant thyroid"
N/I "Those who
displayed weak
mobility for less than
two months after
surgery"
"If patients required an
oral or venous calcium
supplement for less
than 2 months"
N/I "Those who displayed
weak mobility within 2
months after surgery
were considered to
have permanent RLN
injury"
"Permanent
hypoparathyroidism if
the patients required
an oral or venous
calcium supplement
and vitamin D for
more than 2 months
with undetectable
plasma parathyroid
hormone levels"
FNA: fine needle aspiration: N/I: not investigated; RLN: recurrent laryngeal nerve
8 Adverse events (I)
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  Intervention(s) and
comparator(s)
Participants included
in analysis
[N]
Deaths
[N]
Deaths
[%]
All
adverse
events
[N]
All
adverse
events
[%]
Severe/serious
adverse
events
[N]
Severe/serious
adverse
events
[%]
Barczynski
2010
I: total thyroidectomy 191 0 0 47 24.6 4 2.1
C1: Dunhill procedure 189 0 0 28 14.8 4 2.1
C2: bilateral subtotal
thyroidectomy
190 0 0 16 8.4 5 2.6
all:570 0 0 91 16 13 2.3
Giles 2004 I: (near) total
thyroidectomy
109 0 0 28 27 0 0
C: subtotal
thyroidectomy
119 0 0 12 11 0 0
all:218 0 0 40 18.3 0 0
Pappalardo
1998
I: total thyroidectomy 69 0 0 28 40.6 2 2.9
C: subtotal
thyroidectomy
72 0 0 17 23.6 2 2.7
all:141 0 0 45 31.9 4 2.8
Yang 2009 I: (near) total
thyroidectomy
165 0 0 14 8.8 - -
C: subtotal
thyroidectomy
181 0 0 12 6.7 2 1.1
all:346 0 0 26 7.5 N/A N/A
"-" denotes not reported
Dunhill procedure: unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe resection
C: comparator; I: intervention; N/A: not applicable
9 Adverse events (II)
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  Intervention(s)
and
comparator(s)
Participants
included in
analysis
[N]
Participants
discontinuing
study due to
adverse
events
[N]
Participants
discontinuing
study due to
adverse
events
[%]
Rehospitalisation
[N]
Rehospitalisation
[%]
Out-
patient
treatment
[N]
Out-
patient
treatment
[%]
Barczynski
2010
I: total
thyroidectomy
191 0 0 0 0 0 0
C1: Dunhill
procedure
189 0 0 0 0 0 0
C2: bilateral
subtotal
thyroidectomy
190 0 0 0 0 0 0
all:570 0 0 0 0 0 0
Giles
2004
I: (near) total
thyroidectomy
109 0 0 0 0 0 0
C: subtotal
thyroidectomy
109 0 0 4 3.7 0 0
all:218 0 0 4 3.7 0 0
Pappalardo
1998
I: total
thyroidectomy
69 0 0 0 0 0  
C: subtotal
thyroidectomy
72 0 0 0 0 0 0
all:141 0 0 0 0 0 0
Yang
2009
I: (near) total
thyroidectomy
165 6 3.6 0 0 0 0
C: subtotal
thyroidectomy
181 2 1.1 2 1.1 0 0
all:346 8 2.3 2 0.6 0 0
"-" denotes not reported
Dunhill procedure: unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe resection
C: comparator; I: intervention
10 Adverse events (III)
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  Intervention(s)
and
comparator(s)
Participants
included in
analysis
[N]
Permanent
recurrent
laryngeal nerve
palsy
[N] (%)
Transient
recurrent
laryngeal nerve
palsy
[N] (%)
Permanent
hypoparathyroidism
[N] (%)
Transient
hypoparathyroidism
[N] (%)
Barczynski
2010
I: total
thyroidectomy
191 4 (2.1) 21 (11) 1 (0.5) 21 (11)
C1: Dunhill
procedure
189 3 (1.6) 16 (8.5) 0 (0) 8 (4.2)
C2: bilateral
subtotal
thyroidectomy
190 2 (1.1) 8 (4.2) 0 (0) 4 (2.1)
all:570 9 (1.6) 45 (7.9) 1 (0.2) 33 (5.8)
Giles
2004
I: (near) total
thyroidectomy
109 0 (0) 1 (0.9) 0 (0) 2 (1.8)
C: subtotal
thyroidectomy
109 0 (0) 1 (0.9) 0 (0) 1 (0.9)
all:218 0 (0) 2 (0.9) 0 (0) 3 (1.4)
Pappalardo
1998
I: total
thyroidectomy
69 0 (0) 2 (2.9) 2 (2.9) 24 (34.8)
C: subtotal
thyroidectomy
72 1 (1.4) 2 (2.8) 1 (1.4) 13 (18.1)
all:141 1(1.4) 4 (2.8) 3 (2.1) 37 (26.2)
Yang 2009 I: (near) total
thyroidectomy
165 0 (0) 3 (1.9) 0 (0) 11 (6.9)
C: subtotal
thyroidectomy
181 0 (0) 3 (1.7) 0 (0) 9 (5)
all:346 0 (0) 6 (1.8) 0 (0) 20 (5.9)
"-" denotes not reported
Dunhill procedure: unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe resection
C: comparator; I: intervention
11 Survey of authors providing information on included trials
  Study author
contacted
Study author
replied
Study author asked for additional
information
Study author provided
data
Barczynski 2010 Yes Yes Yes Yes
Giles 2004 Yes No N/A N/A
Pappalardo
1998 Yes Yes Yes No
Yang 2009 Yes No N/A N/A
N/A: not applicable
